Guardant Health
342 hedge funds and large institutions have $5.1B invested in Guardant Health in 2025 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 91 increasing their positions, 110 reducing their positions, and 45 closing their positions.
100% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 45
40% more capital invested
Capital invested by funds: $3.65B → $5.1B (+$1.45B)
15% more funds holding
Funds holding: 298 → 342 (+44)
0.28% more ownership
Funds ownership: 96.71% → 97% (+0.28%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
17% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 110
32% less call options, than puts
Call options by funds: $69.7M | Put options by funds: $102M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$91.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$83.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$60.6M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$41.2M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$29.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$123M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
-$65.6M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$59.4M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$42.1M |
| 5 |
Man Group
London,
United Kingdom
|
-$37.1M |
GH Hedge Fund Activity: Q1 2025 in Review
342 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2025, worth a combined $5.1B — up 40% from $3.65B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new GH positions and 45 closed out — a net gain of 45 holders — while 91 added to existing stakes and 110 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $91.2M. The largest seller was Wellington Management Group, cutting an estimated $123M.
- 342 institutional investors held Guardant Health (GH) as of Q1 2025, up from 298 in Q4 2024.
- Funds reported $5.1B of Guardant Health stock for Q1 2025, up 40% quarter-over-quarter.
- 90 funds opened new Guardant Health positions in Q1 2025 and 45 closed out, a net change of +45 holders.
- The largest Guardant Health buyer in Q1 2025 was Citadel Advisors, an estimated $91.2M added.
- The largest Guardant Health seller in Q1 2025 was Wellington Management Group, an estimated $123M sold.
Based on aggregated 13F filings for Q1 2025.